(NP (NP (NP-COOD (NP (JJ SRC-related) (NNS proto-oncogenes)) (CC and) (NP (NN transcription) (NNS factors))) (PP (IN in) (NP (JJ primary) (JJ human) (NN T) (NNS cells))) (: :)) (NP (NP (NN modulation)) (PP (IN by) (NP-COOD (NP (NN cyclosporin) (NN A)) (CC and) (NP (NN FK506)))) (. .)))
(S (NP-SBJ (NP (NN Activation)) (PP (IN of) (NP (NN T) (NNS lymphocytes)))) (VP (VBZ induces) (NP (NP (NN transcription)) (PP (IN of) (NP (NP (NNS genes)) (VP (VBG encoding) (PP (IN for) (NP (NNS lymphokines)))))))) (. .))
(S (NP-SBJ-41 (NP (NP (NN Interleukin-2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-))) (NN gene) (NN expression)) (VP (VBZ is) (VP (VBN controlled) (NP (-NONE- *-41)) (ADVP (RB transcriptionally)) (PP (IN by) (NP-LGS (NP (DT the) (JJ cooperative) (NN activity)) (PP (IN of) (NP (NP (JJ specific) (JJ trans-activating) (NNS factors)) (SBAR (WHNP-42 (WDT that)) (S (NP-SBJ (-NONE- *T*-42)) (VP (VBP bind) (PP (TO to) (NP (DT the) (NN IL-2) (NN enhancer)))))))))))) (. .))
(S (NP-SBJ-COOD (NP (NP (NN Cyclosporin) (NN A)) (PRN (-LRB- -LRB-) (NP (NN CsA)) (-RRB- -RRB-))) (CC and) (NP (NN FK506))) (VP (VBP inhibit) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NN IL-2))) (PP (IN in) (NP (NN T) (NNS lymphocytes))) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN gene) (NN transcription))))))) (. .))
(S (NP-SBJ-43 (NP (NP (DT A) (NN member)) (PP (IN of) (NP (DT the) (NN src) (NN gene) (NN family)))) (, ,) (NP (NP (DT the) (JJ lymphocyte-specific) (NN protein) (NN tyrosine) (NN kinase)) (, ,) (NP (NN p56lck)) (, ,))) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (NP (-NONE- *-43)) (PP (IN in) (NP (NN IL-2) (NN production)))))) (. .))
(S (NP-SBJ-44 (NN CsA)) (VP (VBD was) (VP (VBN found) (S (NP-SBJ (-NONE- *-44)) (VP (RB not) (TO to) (VP (VB inhibit) (NP-COOD (NP (NN lck) (NN gene) (NN expression)) (, ,) (CC nor) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT the) (NN lck) (NN gene) (NN product)))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ-COOD (NP (NN CsA)) (CC and) (NP (NN FK506))) (VP (VBP inhibit) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (NP (NN DNA) (NN binding) (NN activity)) (PP (IN of) (NP (NP (NNS factors)) (SBAR (WHNP-45 (WDT that)) (S (NP-SBJ (-NONE- *T*-45)) (VP (VBP bind) (PP (TO to) (NP (DT the) (NP-COOD (NP (NN NF-AT)) (CC and) (NP (NN AP-1))) (NNS sites))) (PP (IN in) (NP (DT the) (NN IL-2) (NN enhancer)))))))))))) (. .))
(S (SBAR-ADV (IN Since) (S (NP-SBJ-46 (NP (DT the) (NN induction)) (PP (IN of) (NP-COOD (NP (NN NF-AT)) (CC and) (NP (NN AP-1))))) (VP (VBZ is) (VP (VBN induced) (NP (-NONE- *-46)) (PP (IN by) (NP-LGS (NP (DT the) (JJ same) (NNS stimuli)) (SBAR (WHNP-47 (WDT that)) (S (NP-SBJ (-NONE- *T*-47)) (VP (VBP stimulate) (NP (NN IL-2) (NN production))))))))))) (, ,) (NP-SBJ (DT these) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ-48 (NP (DT the) (JJ immunosuppressant) (NN action)) (PP (IN of) (NP-COOD (NP (NN CsA)) (CC and) (NP (NN FK506))))) (VP (VBZ is) (VP (VBN exerted) (NP (-NONE- *-48)) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (DT these) (JJ trans-activating) (NNS factors)))))))))) (. .))
